IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
Nexans projects robust growth with a 36% pre-tax income rise for FY 2024, 1.4B EUR cash flow by 2028, dividends, buybacks & a ...
CD3 T-cell engagers have the potential to be a cornerstone of cancer treatment. They guide the immune system to find and eliminate cancer cells by binding tumor targets and the CD3 protein on ...
Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or " Nano Labs"), a leading fabless integrated circuit design company ...
New companion diagnostics (CDx) collaboration announced with Bayer in China in May 2024.
Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug optimization ...
Ladies and gentlemen, thank you for standing by. The Carnival Corporation & plc conference call will begin momentarily. Again, we thank you for standing by. Please continue […] ...
Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide in the long run. Although no pressure has emerged yet, the 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback